![ProGRP as a Novel Biomarker for the Differential Diagnosis of Medullary Thyroid Carcinoma in Patients with Thyroid Nodules - ScienceDirect ProGRP as a Novel Biomarker for the Differential Diagnosis of Medullary Thyroid Carcinoma in Patients with Thyroid Nodules - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1530891X2035028X-gr4.jpg)
ProGRP as a Novel Biomarker for the Differential Diagnosis of Medullary Thyroid Carcinoma in Patients with Thyroid Nodules - ScienceDirect
![Amazon.com: Permanent Markers & Marker Pens - Permanent Markers & Marker Pens / Markers & Hi...: Office Products Amazon.com: Permanent Markers & Marker Pens - Permanent Markers & Marker Pens / Markers & Hi...: Office Products](https://m.media-amazon.com/images/S/al-na-9d5791cf-3faf/08a44117-11a5-413c-8db9-74da2c193662._SL480_.jpg)
Amazon.com: Permanent Markers & Marker Pens - Permanent Markers & Marker Pens / Markers & Hi...: Office Products
![Prognostic value of tumor markers ProGRP, NSE and CYFRA 21-1 in patients with small cell lung cancer and chemotherapy-induced remission - IOS Press Prognostic value of tumor markers ProGRP, NSE and CYFRA 21-1 in patients with small cell lung cancer and chemotherapy-induced remission - IOS Press](https://content.iospress.com/media/tub-prepress/tub--1--1-tub230016/tub--1-tub230016-g003.jpg)
Prognostic value of tumor markers ProGRP, NSE and CYFRA 21-1 in patients with small cell lung cancer and chemotherapy-induced remission - IOS Press
![Table II from Pro-gastrin-releasing peptide (proGRP) in patients with benign and malignant diseases: comparison with CEA, SCC, CYFRA 21-1 and NSE in patients with lung cancer. | Semantic Scholar Table II from Pro-gastrin-releasing peptide (proGRP) in patients with benign and malignant diseases: comparison with CEA, SCC, CYFRA 21-1 and NSE in patients with lung cancer. | Semantic Scholar](https://ai2-s2-public.s3.amazonaws.com/figures/2017-08-08/d22ee8a6a261d088c448fc6d17d7454209a5f6ea/2-TableII-1.png)
Table II from Pro-gastrin-releasing peptide (proGRP) in patients with benign and malignant diseases: comparison with CEA, SCC, CYFRA 21-1 and NSE in patients with lung cancer. | Semantic Scholar
![Tumor Markers: Physiology, Pathobiology, Technology, and Clinical Applications: 9781890883713: Medicine & Health Science Books @ Amazon.com Tumor Markers: Physiology, Pathobiology, Technology, and Clinical Applications: 9781890883713: Medicine & Health Science Books @ Amazon.com](https://m.media-amazon.com/images/I/A1pYu6qtZkL._AC_UF1000,1000_QL80_.jpg)
Tumor Markers: Physiology, Pathobiology, Technology, and Clinical Applications: 9781890883713: Medicine & Health Science Books @ Amazon.com
![Clinical implications for pro-GRP in small cell lung cancer. A single center experience - Stefano Cavalieri, Daniele Morelli, Antonia Martinetti, Giulia Galli, Federico Nichetti, Filippo de Braud, Marco Platania, 2018 Clinical implications for pro-GRP in small cell lung cancer. A single center experience - Stefano Cavalieri, Daniele Morelli, Antonia Martinetti, Giulia Galli, Federico Nichetti, Filippo de Braud, Marco Platania, 2018](https://journals.sagepub.com/cms/10.5301/ijbm.5000305/asset/images/large/10.5301_ijbm.5000305-fig1.jpeg)
Clinical implications for pro-GRP in small cell lung cancer. A single center experience - Stefano Cavalieri, Daniele Morelli, Antonia Martinetti, Giulia Galli, Federico Nichetti, Filippo de Braud, Marco Platania, 2018
![View of Circulating progastrin-releasing peptide in the diagnosis of Small Cell Lung Cancer (SCLC) and in therapeutic monitoring | Journal of Circulating Biomarkers View of Circulating progastrin-releasing peptide in the diagnosis of Small Cell Lung Cancer (SCLC) and in therapeutic monitoring | Journal of Circulating Biomarkers](https://journals.aboutscience.eu/index.php/jcb/article/download/2212/2385/7673/img04.jpg)